Ayurveda, a branch of AYUSH system of health care in India is considered as alternative/complementary of medicine (CAM) in WHO. Here, its products are covered under “drug and cosmetics” act but in abroad they are supplements or functional foods. The aim of Ayurveda is to maintain the wellness of a healthy person and to treat a patient. For treatment, Ayurveda adopts 3 approaches i.e., (1) Daivavyapasharya (दैवव्यपाश्रय) chikitsa divine therapy) (2) Yuktivyapashraya (युक्तिव्यपाश्रय) chikitsa (Rational therapy) 3 Satvavajaya (सत्वावजय) chikitsa (Psychotherapy) and focuses to enhance the Vyadhikshmatwa (capacity to fight against spread of pathogenesis by strengthening all 7 dhatus (rasa, rakta, meda, mansa, asthi, majja and shukra). The disease COVID-19 falls under “Bhootvidya (GrahaVidya)”, which is one of the 8 branches of “Astanga Ayurveda”. It is an “Agantuja” disease, where the disease symptoms appear in 1^st stage followed by its spread in the body. Thus, progress of disease (Samprapti) has been considered under concept of shatkriyakala (6 stages of disease development), which has been given high importance for deciding the stage of disease progress and its treatment protocol. Here, we have described the introduction to Astang Ayurveda, concept of disease pathogenesis and holistic approach of treatment in respect to management of COVID-19. It specifically covers symptom based stage of disease progress and its targeted treatment guideline by including all 3 approaches of treatment, described above. Here, the current line of diagnosis, treatment and research related to COVID-19 management has been included, which are reported by basic scientists and physicians of allopathic system. These are indexed in Pubmed and web of science and also described in classical text books of Ayurveda. The same has been reviewed and summarized here, with an objective of possible correlation between the 2 languages of science of health care.

中文翻译：

---

COVID-19的管理：阿育吠陀观点

在印度，AYUSH卫生保健系统的一个分支Ayurveda被认为是WHO的替代药物/补充医学（CAM）。在这里，其产品受“药品和化妆品”法保护，但在国外，它们是补品或功能性食品。阿育吠陀的目的是维持健康人的健康并治疗患者。用于治疗，阿育吠陀采用3接近，即，（1）Daivavyapasharya（दैवव्यपाश्रय）chikitsa神圣疗法）（2）Yuktivyapashraya（युक्तिव्यपाश्रय）chikitsa（理性疗法）3 Satvavajaya（सत्वावजय）chikitsa（心理治疗）和着眼于增强Vyadhikshmatwa（通过增强所有7个dhatus（rasa，rakta，meda，mansa，asthi，majja和shukra）的能力来抵抗发病机理的传播。COVID-19疾病属于“ Bhootvidya（GrahaVidya）”，是8个分支之一的“ Astanga阿育吠陀”，它是一种“ Agantuja ”疾病，其中所述疾病症状出现在1个^第一阶段，接着是其在体内的扩散。因此，（疾病的进展Samprapti）已根据的概念考虑shatkriyakala（疾病发展的6个阶段），对于决定疾病进展的阶段及其治疗方案具有高度重要性。在这里，我们已经介绍了阿斯旺阿育吠陀（Astang Ayurveda）的介绍，疾病发病机理的概念以及就COVID-19的管理而言的整体治疗方法。通过包括上述所有3种治疗方法，它特别涵盖了基于症状的疾病进展阶段及其靶向治疗指南。在此，包括了与COVID-19管理相关的当前诊断，治疗和研究领域，这已由同种疗法系统的基础科学家和医师进行了报道。这些在Pubmed和Science of Web中都有索引，在阿育吠陀的经典教科书中也有介绍。此处已对此进行了回顾和总结，